Plant Construction & Process Technology

Outsourcing Biopharmaceutical Manufacturing

12.11.2013 - Development On Trial - The number of biopharmaceutical projects in clinical trials and products is increasing, playing an important role in new treatments. Many of these projects...

Plant Construction & Process Technology

Rethinking Biosimilar Development

08.11.2013 - The World's Biologics Drug Price Problem - Drug expenses have become a significant item in household and government budgets around the world as more innovative and pricey biotech...

Plant Construction & Process Technology

Double Risk with an Upgrade

31.10.2013 - Trial And Error - Despite a 150-year history and an aggregate R&D expenditure of $150 billion per year, innovation in the modern pharmaceutical industry is essentially still based...

Plant Construction & Process Technology

Sourcing from India and China

30.10.2013 - 'Pharmacy To The World' - In today's global pharmaceutical industry 2.0, emerging regions led by India (BRIC - Brazil, Russia, India, China) have moved to the front row in terms of...

Plant Construction & Process Technology

A Shaky Platform?

29.10.2013 - Monitoring The Supply Chain - The globalization of chemical raw material procurement is presenting significant challenges to the pharmaceutical industry. Adopting basic good...

Plant Construction & Process Technology

Russia’s and Eastern Europe’s Booming Pharma Industry

28.10.2013 - Potential For Success - There is great promise for innovative R&D, generics and active pharmaceutical ingredient (API) manufacture in Russia and the countries that make up Central...

Plant Construction & Process Technology

Camelot’s Pharma Management Radar

24.10.2013 - End Of Patent Protection - The global pharmaceutical industry is steering toward the patent cliff: Some of the biggest blockbuster drugs in history - Lipitor, Plavix and Viagra -...

Plant Construction & Process Technology

Ashland’s Jeff Wolff on the Importance of Innovation

24.10.2013 - Transfomer - It was one of the biggest headlines of 2011 - Ashland Closes ISP Acquisition For $3.2 Billion.When the Kentucky-based specialty chemicals company wrapped up the deal...